- Product Details
Keywords
- озагрел
- Inhibit thrombosi
- movement disorders
Quick Details
- ProName: Ozagrel Peptides API for Antiplatelet ...
- CasNo: 82571-53-7
- Molecular Formula: C13h12n2o2
- Appearance: white to off white
- Application: White white crystall powder 0.995 | po...
- DeliveryTime: Ready in Stock
- PackAge: Aluminum Foil Bag
- Port: HK/Shenzhen
- ProductionCapacity: 500 Kilogram/Year
- Purity: ≥98%
- Storage: 2-8 degree
- Transportation: Cold chain and cool storage delivery f...
- LimitNum: 1 Gram
Superiority
The first listed company in peptides industry, mature process, stable and advaced technology,API capacity reaches to 500kg with 3 main factory sites.
Details
Specification
Ozagrel is a potent and selective thromboxane A2 synthetase inhibitor with an IC50 of 4 nM. It does not inhibit prostacyclin (PGI2) synthetase, cyclooxygenase or PGE2 isomerase (IC50 > 1 mM). Inhibits platelet aggregation in vitro and arachidonate-induced arterial contraction in vivo. The beneficial effects of TXAS inhibition by ozagrel include improved motor coordination after experimental stroke and antihypertensive effects in spontaneously hypertensive rats